EUVIMEDEUVIMED entdecken
Crossref

The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients

Yusuf Uzum, Tarik Salman, Utku Oflazoglu, Yasar Yildiz, Umut Varol, Murat Aysin, Yuksel Kucukzeybek, Ahmet Alacacioglu, Mustafa Oktay Tarhan

Bratislava Medical Journal · 2024

DOI: 10.4149/bll_2024_71 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bratislava Medical Journal, 2024. Verfasst von Yusuf Uzum und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glioblastoma, Neutrophils, Brain Neoplasms, Lymphocytes. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Individuals with a higher De Ritis ratio (aspartate transaminase/alanine transaminase) and neutrophil-to-lymphocyte ratio (NLR) have an inferior survival in varied malignancies. To our knowledge, the prognostic potential of the De Ritis ratio and NLR to predict the survival in nonmetastatic glioblastoma multiforme (GBM) patients remains unclear. In this study, we aimed to explore the prognostic power of the De Ritis ratio and NLR in patients with nonmetastatic glioblastoma multiforme. METHODS: Data of 262 patients with glioblastoma multiforme have been retrospectively analyzed. Their age, gender, tumor characteristics, AST/ALT ratio, NLR and hemogram values, including age at diagnosis and date of diagnosis were recorded. RESULTS: The median survival time of the study group was 21 months (95% CI: 19‒23 months). The first-year and second-year survival rates were 73.0% and 40.5%, respectively. The univariate analysis revealed that the correlation of survival with age, gender, left/right location of tumor, mean platelet volume and De Ritis ratio did not reach the level of significance. The univariate analysis of the prognostic potential of NLR indicated that a 1-unit increase in NLR value translates to a 1.05 times higher risk of death (95% CI: 1.01‒1.09). CONCLUSION: The results of this study lead to the observation that NLR value can serve as an effective prognostic marker in predicting the outcomes of patients with glioblastoma multiforme. It can be positioned as an easily accessible and cost-effective biomarker for establishing appropriate therapeutic strategies (Tab. 2, Fig. 1, Ref. 20).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaNeutrophilsBrain NeoplasmsLymphocytesHumansMaleFemalePrognosisMiddle AgedRetrospective StudiesAdultAgedAlanine TransaminaseAspartate AminotransferasesSurvival RateLymphocyte CountLeukocyte CountYoung Adult

Stichwörter der Autor:innen

De Ritis ratioglioblastoma multiforme malignancy.neutrophil-to-lymphocyte ratio

Substanzen

Alanine TransaminaseAspartate Aminotransferases

Zitieren

APA

Uzum, Y., Salman, T., Oflazoglu, U., Yildiz, Y., Varol, U., Aysin, M., Kucukzeybek, Y., Alacacioglu, A., & Tarhan, M. O. (2024). The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_71

Vancouver

Uzum Y, Salman T, Oflazoglu U, Yildiz Y, Varol U, Aysin M, et al. The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients. Bratislava Medical Journal. 2024. doi:10.4149/bll_2024_71

BibTeX
@article{Uzum2024,
  author = {Uzum, Yusuf and Salman, Tarik and Oflazoglu, Utku and Yildiz, Yasar and Varol, Umut and Aysin, Murat and Kucukzeybek, Yuksel and Alacacioglu, Ahmet and Tarhan, Mustafa Oktay},
  title = {The prognostic effect of neutrophil-to-lymphocyte ratio and De Ritis ratio in glioblastoma multiforme patients},
  journal = {Bratislava Medical Journal},
  year = {2024},
  doi = {10.4149/bll_2024_71}
}
Kostenlos starten →